Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Evaluate if the two carboplatin containing chemotherapy regimens will reduce the growth of
breast cancer cells in women with Stage I, II, or III triple negative breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Priyanka Sharma University of Kansas Medical Center